Design, Synthesis and antiHIV activity of Novel Isatine-Sulphonamides
2008

Anti-HIV Activity of Novel Isatine-Sulphonamides

publication Evidence: moderate

Author Information

Author(s): Selvam P., Murugesh N., Chandramohan M., Debyser Z., Witvrouw M.

Primary Institution: Arulmigu Kalasalingam College of Pharmacy

Hypothesis

The study investigates the anti-HIV activity of synthesized isatine-sulphonamide derivatives.

Conclusion

Some isatine-sulphonamide derivatives showed significant inhibitory effects against HIV-1 replication.

Supporting Evidence

  • 4-(1-acetyl-5-methyl-2-oxoindolin-3-ylideneamino)-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide inhibits HIV Integrase enzymatic activity.
  • 4-(1-benzoyl-5-chloro-2-oxoindolin-3-ylideneamino)-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide exhibits 36 percent maximum protection against HIV-1.
  • None of the compounds exhibited anti-HIV effect and all displayed cytotoxic properties in MT-4 cells.

Takeaway

The researchers made new compounds and found that some can help fight HIV, but they also found that these compounds can be harmful to cells.

Methodology

The compounds were synthesized and tested for anti-HIV activity in MT-4 cells using various assays.

Limitations

The compounds exhibited cytotoxic properties in the lymphocyte cell line (MT-4 cells).

Digital Object Identifier (DOI)

10.4103/0250-474X.49121

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication